Cancer Fighters Companies By Shares Outstanding

LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Shares Outstanding
Return On Equity
Return On Asset
Profit Margin
Operating Margin
Current Valuation
Shares Outstanding
Shares Owned By Insiders
Shares Owned By Institutions
Number Of Shares Shorted
Price To Earning
Price To Book
Price To Sales
Revenue
Gross Profit
EBITDA
Net Income
Cash And Equivalents
Cash Per Share
Total Debt
Debt To Equity
Current Ratio
Book Value Per Share
Cash Flow From Operations
Short Ratio
Earnings Per Share
Price To Earnings To Growth
Target Price
Number Of Employees
Beta
Market Capitalization
Total Asset
Retained Earnings
Working Capital
Current Asset
Current Liabilities
Shares OutstandingEfficiencyMarket RiskExp Return
1GERN Geron
604.5 M
(0.02)
 2.74 
(0.07)
2IOVA Iovance Biotherapeutics
304.78 M
(0.03)
 4.32 
(0.14)
3BDX Becton Dickinson and
289.12 M
(0.11)
 1.17 
(0.12)
4ADAP Adaptimmune Therapeutics Plc
255.88 M
(0.15)
 4.64 
(0.70)
5HCM HUTCHMED DRC
170.94 M
 0.00 
 3.37 
 0.01 
6TGTX TG Therapeutics
155.66 M
 0.18 
 4.12 
 0.76 
7HRTX Heron Therapeuti
152.1 M
(0.09)
 5.02 
(0.44)
8ARRY Array Technologies
151.94 M
 0.04 
 6.02 
 0.26 
9HALO Halozyme Therapeutics
127.23 M
(0.08)
 3.77 
(0.30)
10KPTI Karyopharm Therapeutics
125.31 M
 0.07 
 5.20 
 0.39 
11MRSN Mersana Therapeutics
123.53 M
 0.14 
 6.59 
 0.92 
12MESO Mesoblast
114.18 M
 0.18 
 5.10 
 0.94 
13NVCR Novocure
108.2 M
 0.09 
 4.14 
 0.36 
14REGN Regeneron Pharmaceuticals
108.07 M
(0.39)
 1.72 
(0.68)
15ZLAB Zai Lab
107.45 M
 0.17 
 4.06 
 0.71 
16FGEN FibroGen
100.77 M
 0.09 
 6.43 
 0.58 
17CLLS Cellectis SA
100.09 M
(0.02)
 3.17 
(0.07)
18BGNE BeiGene
97.43 M
 0.09 
 2.62 
 0.24 
19CTMX CytomX Therapeutics
78.26 M
(0.01)
 3.68 
(0.02)
20PTCT PTC Therapeutics
77.13 M
 0.14 
 3.56 
 0.49 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds. Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY